Literature DB >> 2590220

Identification of angiotensin II receptor subtypes.

A T Chiu1, W F Herblin, D E McCall, R J Ardecky, D J Carini, J V Duncia, L J Pease, P C Wong, R R Wexler, A L Johnson.   

Abstract

We have demonstrated the existence of two distinct subtypes of the angiotensin II receptor in the rat adrenal gland using radioligand binding and tissue section autoradiography. The identification of the subtypes was made possible by the discovery of two structurally dissimilar, nonpeptide compounds, DuP 753 and EXP655, that show reciprocal selectivity for the two subtypes. In the rat adrenal cortex, DuP 753 inhibited 80% of the total AII binding with an IC50 value on the sensitive sites of 2 x 10(-8) M, while EXP655 displaced only 20%. In the rat adrenal medulla, EXP655 gave 90% inhibition of AII binding with an IC50 value of 3.0 x 10(-8) M, while DuP 753 was essentially inactive. The combination of the two compounds completely inhibited AII binding in both tissues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2590220     DOI: 10.1016/0006-291x(89)91054-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  88 in total

1.  Evidence for involvement of 3'-untranslated region in determining angiotensin II receptor coupling specificity to G-protein.

Authors:  Thomas J Thekkumkara; Stuart L Linas
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

2.  Blood pressure and dementia - a comprehensive review.

Authors:  Sean P Kennelly; Brian A Lawlor; Rose Anne Kenny
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

3.  Pharmacological characterization of angiotensin II AT(2) receptor subtype heterogeneity in the rat adrenal cortex and medulla.

Authors:  X Lu; K L Grove; W Zhang; R C Speth
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

Review 4.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

5.  Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.

Authors:  Alia Shatanawi; Maritza J Romero; Jennifer A Iddings; Surabhi Chandra; Nagavedi S Umapathy; Alexander D Verin; Ruth B Caldwell; R William Caldwell
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

6.  High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats.

Authors:  Dong You; Laurent Loufrani; Celine Baron; Bernard I Levy; Robert E Widdop; Daniel Henrion
Journal:  Circulation       Date:  2005-02-14       Impact factor: 29.690

7.  The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

Authors:  M Nakajima; H G Hutchinson; M Fujinaga; W Hayashida; R Morishita; L Zhang; M Horiuchi; R E Pratt; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

8.  Comparative pharmacology of recombinant rat AT1A, AT1B and human AT1 receptors expressed by transfected COS-M6 cells.

Authors:  A J Balmforth; S E Bryson; A J Aylett; P Warburton; S G Ball; K T Pun; D Middlemiss; G M Drew
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

9.  Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog.

Authors:  K L Clark; M J Robertson; G M Drew
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

10.  Pharmacological characterization of the contractile responses to angiotensin analogues in guinea-pig isolated longitudinal muscle of small intestine.

Authors:  A B Hawcock; J C Barnes
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.